ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Rare Diseases : Bile Duct Neoplasms

Include trials that are no longer recruiting patients.

6 studies were found.
1.RecruitingBortezomib as First-Line Systemic Therapy in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
2.Recruiting3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer
Conditions: unresectable extrahepatic bile duct cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; recurrent extrahepatic bile duct cancer; ...
3.RecruitingAdjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer; Pain
4.RecruitingGemcitabine and Capecitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Conditions: extrahepatic bile duct cancer; Gallbladder Cancer
5.RecruitingBMS-247550 in Treating Patients With Liver or Gallbladder Cancer
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
6.RecruitingRebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
Conditions: adult primary liver cancer; cholangiocarcinoma of the extrahepatic bile duct; cholangiocarcinoma of the gallbladder; ...

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act